Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency.

PubWeight™: 2.41‹?› | Rank: Top 2%

🔗 View Article (PMID 6982014)

Published in Ann Intern Med on October 01, 1982

Authors

H Masur, M A Michelis, G P Wormser, S Lewin, J Gold, M L Tapper, J Giron, C W Lerner, D Armstrong, U Setia, J A Sender, R S Siebken, P Nicholas, Z Arlen, S Maayan, J A Ernst, F P Siegal, S Cunningham-Rundles

Articles citing this

Techniques for the recovery and identification of Cryptosporidium oocysts from stool specimens. J Clin Microbiol (1983) 6.16

Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol (1983) 3.36

Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol (1989) 1.85

The acquired immune deficiency syndrome. Clin Exp Immunol (1984) 1.62

AIDS: acquired immunodeficiency syndrome. Can Med Assoc J (1983) 1.48

Acquired immune deficiency syndrome. Br Med J (Clin Res Ed) (1983) 1.19

Psychiatric problems of AIDS inpatients at the New York Hospital: preliminary report. Public Health Rep (1984) 1.13

Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Rep (1995) 1.11

Pneumocystis pneumonia. Br Med J (Clin Res Ed) (1983) 1.10

Neuropathologic observations in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol (1985) 1.08

Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax (1985) 1.03

Pneumocystis carinii antigenemia in adults with malignancy, infection, or pulmonary disease. J Clin Microbiol (1984) 0.98

Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture. Antimicrob Agents Chemother (1983) 0.96

The acquired immune deficiency syndrome (AIDS)--a multidisciplinary enigma. West J Med (1984) 0.96

Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome. J Clin Invest (1984) 0.93

AIDS: sense not fear. Br Med J (Clin Res Ed) (1984) 0.86

AIDS in Haitian immigrants and in a Caucasian woman closely associated with Haitians. Can Med Assoc J (1983) 0.85

The Acquired Immunodeficiency Syndrome: current status. Yale J Biol Med (1983) 0.80

HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs. Public Health Rep (1988) 0.79

Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS). J Clin Invest (1983) 0.79

Heterosexual transmission of human immunodeficiency virus infection - Strategies for prevention. Can J Infect Dis (1991) 0.75

Acquired immune deficiency syndrome. Br Med J (Clin Res Ed) (1983) 0.75

AIDS: acquired immunodeficiency syndrome. 1983. CMAJ (1992) 0.75

Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU). Yale J Biol Med (1988) 0.75

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users. AIDS Res Ther (2015) 0.75

Articles by these authors

Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med (1999) 14.30

Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09

An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med (1981) 7.35

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med (1999) 7.07

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 6.79

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med (2001) 6.76

NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45

Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31

Effect of a general practitioner's consulting style on patients' satisfaction: a controlled study. BMJ (1990) 6.15

Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet (1986) 5.65

Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25

Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol (1985) 5.22

Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature (1988) 5.21

Referral to hospital: perceptions of patients, general practitioners and consultants about necessity and suitability of referral. Fam Pract (1987) 5.11

A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96

Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron (1998) 4.92

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet (1985) 4.83

Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38

Comparison of criteria derived by government and patients for evaluating general practitioner services. BMJ (1989) 4.36

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med (1981) 4.31

Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.02

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis (1985) 4.00

Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80

Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet (1989) 3.74

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med (1984) 3.73

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ (1999) 3.62

Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med (1982) 3.58

Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55

Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45

Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41

Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun (1999) 3.41

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med (1997) 3.40

Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet (1985) 3.33

Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet (1997) 3.32

Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis (1972) 3.28

Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med (1994) 3.25

Identification of human B and T lymphocytes by scanning electron microscopy. J Exp Med (1973) 3.21

Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science (1984) 3.20

Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med (1985) 3.19

Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16

Reasons for referral to hospital: extent of agreement between the perceptions of patients, general practitioners and consultants. Fam Pract (1986) 3.14

Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2. Lancet (1992) 3.13

Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12

Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol (1986) 3.12

Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol (1983) 3.09

The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06

Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (1997) 3.06

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med (2001) 3.05

Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro. J Immunol (1977) 3.04

A reevaluation of cancer incidence near the Three Mile Island nuclear plant: the collision of evidence and assumptions. Environ Health Perspect (1997) 3.04

Investigation of burnout in a sample of British general practitioners. Br J Gen Pract (1995) 3.03

Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02

Intraorbital wood. Detection by magnetic resonance imaging. Ophthalmology (1990) 2.99

Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol (1995) 2.97

The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med (1978) 2.93

Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med (1977) 2.92

Measuring general practitioner referrals: patient, workload and list size effects. J R Coll Gen Pract (1988) 2.91

Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia. J Clin Microbiol (1985) 2.86

Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol (1971) 2.86

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther (2003) 2.83

Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med (1984) 2.80

Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg (1989) 2.79

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med (1993) 2.78

Impact of color blindness on recognition of blood in body fluids. Arch Intern Med (2001) 2.78

Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol (1999) 2.73

Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71

Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry (1995) 2.69

Serodiagnosis in early Lyme disease. J Clin Microbiol (1993) 2.69

Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69

Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med (1997) 2.69

NIH conference. The acquired immunodeficiency syndrome: an update. Ann Intern Med (1985) 2.68

Preferences of healthy and ill patients for style of general practitioner care: implications for workload and financial incentives under the new contract. Br J Gen Pract (1991) 2.66

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

Telephone consultations in general practice: an additional or alternative service? Br J Gen Pract (1995) 2.62

Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol (1971) 2.60

Infection due to Leuconostoc species: six cases and review. Rev Infect Dis (1990) 2.58

Lyme borreliosis. Lancet (1998) 2.57

Septicemia due to Aeromonas hydrophila: clinical and immunologic aspects. J Infect Dis (1973) 2.55

Oxidative damage to DNA in diabetes mellitus. Lancet (1996) 2.54

Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51

Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract (2001) 2.50

Patients' views of priority setting in health care: an interview survey in one practice. BMJ (1995) 2.50

Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci U S A (1987) 2.48

Serious infections caused by Streptococcus milleri. Am J Med (1978) 2.47

Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet (1985) 2.45

Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44

Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol (1996) 2.43

Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med (1988) 2.42

Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol (1982) 2.42